Lomond Therapeutics

Lomond Therapeutics is a small molecule oncology drug discovery company committed to defeating and curing cancer. Many malignant tumors develop resistance to treatment through mutations or escape mechanisms that limit current therapeutics, so Lomond develops differentiated small molecules targeting the fundamental biological pathways behind that resistance in hematologic malignancies. By pursuing pan-variant therapies that address the major drivers of cancer resistance, the company aims to overcome the limitations of existing oncology treatments and deliver first-in-class and best-in-class therapeutics for hematologic malignancies.